{
  "question": "Which of the following anti-tubercular drug is avoided in a HIV positive patient on zidovudine, lamivudine and indinavir therapy who develops TB?",
  "is_multi_choice": true,
  "correct_answer": "opd",
  "options": {
    "opa": "Pyrazinamide",
    "opb": "Isoniazid",
    "opc": "Ethambutol",
    "opd": "Rifampicin"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "causal_graph": {
    "nodes": [
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Tuberculosis",
        "Disease",
        "Drug Interactions"
      ],
      [
        "Tuberculosis",
        "Myopathy",
        "Drug Interactions"
      ],
      [
        "Tuberculosis",
        "Obesity",
        "Drug Interactions"
      ],
      [
        "Drug Interactions",
        "Disease",
        "HIV"
      ],
      [
        "Drug Interactions",
        "Cardiovascular Diseases",
        "HIV"
      ],
      [
        "Drug Interactions",
        "Tuberculosis",
        "HIV"
      ]
    ],
    "relationships": [
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "CAUSES",
        "CAUSES"
      ],
      [
        "CAUSES",
        "CAUSES"
      ],
      [
        "PREDISPOSES",
        "CAUSES"
      ],
      [
        "CAUSES",
        "PROCESS_OF"
      ],
      [
        "CAUSES",
        "PROCESS_OF"
      ],
      [
        "CAUSES",
        "PROCESS_OF"
      ]
    ],
    "paths": [
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Tuberculosis)-CAUSES->(Disease)-CAUSES->(Drug Interactions)",
      "(Tuberculosis)-CAUSES->(Myopathy)-CAUSES->(Drug Interactions)",
      "(Tuberculosis)-PREDISPOSES->(Obesity)-CAUSES->(Drug Interactions)",
      "(Drug Interactions)-CAUSES->(Disease)-PROCESS_OF->(HIV)",
      "(Drug Interactions)-CAUSES->(Cardiovascular Diseases)-PROCESS_OF->(HIV)",
      "(Drug Interactions)-CAUSES->(Tuberculosis)-PROCESS_OF->(HIV)"
    ]
  },
  "knowledge_graph": {
    "nodes": [
      [
        "HIV",
        "2019 novel coronavirus",
        "Lamivudine"
      ],
      [
        "HIV",
        "Hepatitis B Virus",
        "Lamivudine"
      ],
      [
        "Enzymes",
        "physiological aspects",
        "Lamivudine"
      ],
      [
        "Enzymes",
        "Liver",
        "Lamivudine"
      ],
      [
        "Cytochrome P450",
        "Disease",
        "Hepatitis B Virus",
        "Lamivudine"
      ],
      [
        "Cytochrome P450",
        "Disease",
        "2019 novel coronavirus",
        "Lamivudine"
      ],
      [
        "HIV",
        "2019 novel coronavirus",
        "Lamivudine"
      ],
      [
        "HIV",
        "Hepatitis B Virus",
        "Lamivudine"
      ],
      [
        "isoniazid",
        "Disease",
        "Pathogenesis",
        "NPM1 gene|NPM1",
        "Ethambutol"
      ],
      [
        "isoniazid",
        "Disease",
        "Pathogenesis",
        "NPM1 gene|NPM1",
        "Ethambutol"
      ],
      [
        "HIV",
        "2019 novel coronavirus",
        "Lamivudine"
      ],
      [
        "HIV",
        "Hepatitis B Virus",
        "Lamivudine"
      ]
    ],
    "relationships": [
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "CAUSES",
        "ASSOCIATED_WITH"
      ],
      [
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "ASSOCIATED_WITH",
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "ASSOCIATED_WITH",
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "TREATS",
        "PREDISPOSES",
        "ASSOCIATED_WITH",
        "INTERACTS_WITH"
      ],
      [
        "TREATS",
        "MANIFESTATION_OF",
        "ASSOCIATED_WITH",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ],
      [
        "INTERACTS_WITH",
        "LOCATION_OF"
      ]
    ],
    "paths": [
      "(HIV)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(HIV)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)",
      "(Enzymes)-CAUSES->(physiological aspects)-ASSOCIATED_WITH->(Lamivudine)",
      "(Enzymes)-PART_OF->(Liver)-LOCATION_OF->(Lamivudine)",
      "(Cytochrome P450)-ASSOCIATED_WITH->(Disease)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)",
      "(Cytochrome P450)-ASSOCIATED_WITH->(Disease)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(HIV)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(HIV)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)",
      "(isoniazid)-TREATS->(Disease)-PREDISPOSES->(Pathogenesis)-ASSOCIATED_WITH->(NPM1 gene|NPM1)-INTERACTS_WITH->(Ethambutol)",
      "(isoniazid)-TREATS->(Disease)-MANIFESTATION_OF->(Pathogenesis)-ASSOCIATED_WITH->(NPM1 gene|NPM1)-INTERACTS_WITH->(Ethambutol)",
      "(HIV)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(HIV)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)"
    ]
  },
  "enhanced_graph": {
    "nodes": [],
    "relationships": [],
    "paths": [
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(HIV)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(HIV)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)",
      "(Cytochrome P450)-ASSOCIATED_WITH->(Disease)-INTERACTS_WITH->(Hepatitis B Virus)-LOCATION_OF->(Lamivudine)",
      "(Cytochrome P450)-ASSOCIATED_WITH->(Disease)-INTERACTS_WITH->(2019 novel coronavirus)-LOCATION_OF->(Lamivudine)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(isoniazid)-TREATS->(Disease)-MANIFESTATION_OF/PREDISPOSES->(Pathogenesis)-ASSOCIATED_WITH->(NPM1 gene|NPM1)-INTERACTS_WITH->(Ethambutol)",
      "(Drug Interactions)-CAUSES->(Tuberculosis)-PROCESS_OF->(HIV)"
    ]
  },
  "reasoning_chain": [
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, and indinavir\" -> \"develops TB\" -> \"requires anti-tubercular therapy\" -> \"Rifampicin is a potent inducer of CYP450 enzymes\" -> \"may decrease levels of zidovudine and lamivudine\" -> \"risk of treatment failure or toxicity\" -> 85%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, and indinavir\" -> \"develops TB\" -> \"needs anti-tubercular drugs\" -> \"Isoniazid is generally safe\" -> \"Ethambutol is also safe\" -> \"Pyrazinamide may have some interactions\" -> \"but Rifampicin is the most concerning\" -> 90%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, and indinavir\" -> \"develops TB\" -> \"consideration of drug interactions\" -> \"Rifampicin can reduce effectiveness of HIV medications\" -> \"increased risk of adverse effects\" -> \"therefore, Rifampicin is avoided\" -> 95%"
  ],
  "enhanced_information": "In HIV positive patients on zidovudine, lamivudine, and indinavir therapy who develop TB, Rifampicin is avoided due to its potent induction of CYP450 enzymes, which can significantly decrease the plasma levels of zidovudine and lamivudine, leading to a risk of treatment failure or increased toxicity. Isoniazid and Ethambutol are generally considered safe in this context, while Pyrazinamide may have some interactions but is less concerning than Rifampicin. Therefore, the consensus is that Rifampicin poses the greatest risk of adverse drug interactions in this scenario.",
  "analysis": "In the context of treating tuberculosis in an HIV-positive patient on zidovudine, lamivudine, and indinavir, the primary concern is drug-drug interactions. Rifampicin is a potent inducer of the cytochrome P450 enzyme system, particularly CYP3A4, which can significantly reduce the plasma concentrations of protease inhibitors like indinavir. This interaction can lead to subtherapeutic levels of indinavir, risking HIV treatment failure. Additionally, Rifampicin can also affect the levels of zidovudine and lamivudine, although to a lesser extent. The other anti-tubercular drugs listed (Pyrazinamide, Isoniazid, and Ethambutol) do not have such significant interactions with the antiretroviral drugs mentioned. Therefore, the consensus is to avoid Rifampicin in this scenario to prevent these interactions and maintain effective HIV therapy.",
  "answer": "opd",
  "confidence": 95.0,
  "chain_coverage": {
    "success_counts": [
      6,
      5,
      6
    ],
    "coverage_rates": [
      35.294117647058826,
      29.411764705882355,
      35.294117647058826
    ],
    "total_successes": 17
  },
  "normal_results": []
}